Guided Therapeutics (GTHP) Revenue (2010 - 2025)
Guided Therapeutics' (GTHP) quarterly Revenue came in at $590000.0 in Q4 2025, up 58900.0% year-on-year from N/an in Q4 2024, and up 883.33% quarter-over-quarter from $60000.0 in Q3 2025.
Guided Therapeutics (GTHP) Revenue (2010 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Revenue across 16 years of filings, most recently posting $590000.0 for Q4 2025.
- Revenue for Q4 2025 came in at $590000.0, up 58900.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $767000.0 (up 10857.14% YoY), and the FY2025 annual result was $767000.0, up 10857.14% from the prior year.
- Revenue came in at $590000.0 for Q4 2025 at Guided Therapeutics, up from $60000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $590000.0 in Q4 2025 to a low of $1000.0 in Q4 2024.
- The 5-year median for Revenue is $20500.0 (2021), against an average of $69000.0.
- Across the five-year window, Revenue plunged 96.88% in 2024 and soared 58900.0% in 2025, its largest moves.
- Guided Therapeutics' Revenue stood at $60000.0 in 2021, then tumbled by 95.0% to $3000.0 in 2022, then jumped by 966.67% to $32000.0 in 2023, then slumped by 96.88% to $1000.0 in 2024, then jumped by 58900.0% to $590000.0 in 2025.
- The last three Revenue figures came in at $590000.0 (Q4 2025), $60000.0 (Q3 2025), and $117000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.02 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.57 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.19 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.59 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 590,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Sep 30, 2020 | 77,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 18,000.00 |